Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,287,869
-
Share change
-
-1,182,470
-
Total reported value
-
$16,937,000
-
Price per share
-
$1.04
-
Number of holders
-
35
-
Value change
-
-$584,055
-
Number of buys
-
15
-
Number of sells
-
13
Institutional Holders of ONCOMED PHARMACEUTICALS INC - COM (OMED) as of Q1 2019
As of 31 Mar 2019,
ONCOMED PHARMACEUTICALS INC - COM (OMED) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,287,869 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, PERCEPTIVE ADVISORS LLC, Candriam Luxembourg S.C.A., Birchview Capital, LP, VANGUARD GROUP INC, CANNELL PETER B & CO INC, ACADIAN ASSET MANAGEMENT LLC, and BlackRock Inc..
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.